1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Neuroblastoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Combination Chemotherapy 1.2.3 Monoclonal Antibody Therapy 1.2.4 Vaccine Therapy 1.2.5 Chimeric Antigen Receptor T-Cell Immunotherapy 1.2.6 Oncolytic Virus Therapy 1.3 Market by Application 1.3.1 Global Neuroblastoma Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Neuroblastoma Treatment Market Perspective (2016-2027) 2.2 Neuroblastoma Treatment Growth Trends by Regions 2.2.1 Neuroblastoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Neuroblastoma Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Neuroblastoma Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Neuroblastoma Treatment Industry Dynamic 2.3.1 Neuroblastoma Treatment Market Trends 2.3.2 Neuroblastoma Treatment Market Drivers 2.3.3 Neuroblastoma Treatment Market Challenges 2.3.4 Neuroblastoma Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Neuroblastoma Treatment Players by Revenue 3.1.1 Global Top Neuroblastoma Treatment Players by Revenue (2016-2021) 3.1.2 Global Neuroblastoma Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Neuroblastoma Treatment Revenue 3.4 Global Neuroblastoma Treatment Market Concentration Ratio 3.4.1 Global Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Neuroblastoma Treatment Revenue in 2020 3.5 Neuroblastoma Treatment Key Players Head office and Area Served 3.6 Key Players Neuroblastoma Treatment Product Solution and Service 3.7 Date of Enter into Neuroblastoma Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Neuroblastoma Treatment Breakdown Data by Type 4.1 Global Neuroblastoma Treatment Historic Market Size by Type (2016-2021) 4.2 Global Neuroblastoma Treatment Forecasted Market Size by Type (2022-2027) 5 Neuroblastoma Treatment Breakdown Data by Application 5.1 Global Neuroblastoma Treatment Historic Market Size by Application (2016-2021) 5.2 Global Neuroblastoma Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Neuroblastoma Treatment Market Size (2016-2027) 6.2 North America Neuroblastoma Treatment Market Size by Type 6.2.1 North America Neuroblastoma Treatment Market Size by Type (2016-2021) 6.2.2 North America Neuroblastoma Treatment Market Size by Type (2022-2027) 6.2.3 North America Neuroblastoma Treatment Market Size by Type (2016-2027) 6.3 North America Neuroblastoma Treatment Market Size by Application 6.3.1 North America Neuroblastoma Treatment Market Size by Application (2016-2021) 6.3.2 North America Neuroblastoma Treatment Market Size by Application (2022-2027) 6.3.3 North America Neuroblastoma Treatment Market Size by Application (2016-2027) 6.4 North America Neuroblastoma Treatment Market Size by Country 6.4.1 North America Neuroblastoma Treatment Market Size by Country (2016-2021) 6.4.2 North America Neuroblastoma Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Neuroblastoma Treatment Market Size (2016-2027) 7.2 Europe Neuroblastoma Treatment Market Size by Type 7.2.1 Europe Neuroblastoma Treatment Market Size by Type (2016-2021) 7.2.2 Europe Neuroblastoma Treatment Market Size by Type (2022-2027) 7.2.3 Europe Neuroblastoma Treatment Market Size by Type (2016-2027) 7.3 Europe Neuroblastoma Treatment Market Size by Application 7.3.1 Europe Neuroblastoma Treatment Market Size by Application (2016-2021) 7.3.2 Europe Neuroblastoma Treatment Market Size by Application (2022-2027) 7.3.3 Europe Neuroblastoma Treatment Market Size by Application (2016-2027) 7.4 Europe Neuroblastoma Treatment Market Size by Country 7.4.1 Europe Neuroblastoma Treatment Market Size by Country (2016-2021) 7.4.2 Europe Neuroblastoma Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Neuroblastoma Treatment Market Size (2016-2027) 8.2 Asia-Pacific Neuroblastoma Treatment Market Size by Type 8.2.1 Asia-Pacific Neuroblastoma Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Neuroblastoma Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Neuroblastoma Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Neuroblastoma Treatment Market Size by Application 8.3.1 Asia-Pacific Neuroblastoma Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Neuroblastoma Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Neuroblastoma Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Neuroblastoma Treatment Market Size by Region 8.4.1 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Neuroblastoma Treatment Market Size (2016-2027) 9.2 Latin America Neuroblastoma Treatment Market Size by Type 9.2.1 Latin America Neuroblastoma Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Neuroblastoma Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Neuroblastoma Treatment Market Size by Type (2016-2027) 9.3 Latin America Neuroblastoma Treatment Market Size by Application 9.3.1 Latin America Neuroblastoma Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Neuroblastoma Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Neuroblastoma Treatment Market Size by Application (2016-2027) 9.4 Latin America Neuroblastoma Treatment Market Size by Country 9.4.1 Latin America Neuroblastoma Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Neuroblastoma Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Neuroblastoma Treatment Market Size (2016-2027) 10.2 Middle East & Africa Neuroblastoma Treatment Market Size by Type 10.2.1 Middle East & Africa Neuroblastoma Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Neuroblastoma Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Neuroblastoma Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Neuroblastoma Treatment Market Size by Application 10.3.1 Middle East & Africa Neuroblastoma Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Neuroblastoma Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Neuroblastoma Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Neuroblastoma Treatment Market Size by Country 10.4.1 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Seattle Children’s 11.1.1 Seattle Children’s Company Details 11.1.2 Seattle Children’s Business Overview 11.1.3 Seattle Children’s Neuroblastoma Treatment Introduction 11.1.4 Seattle Children’s Revenue in Neuroblastoma Treatment Business (2016-2021) 11.1.5 Seattle Children’s Recent Development 11.2 CureSearch 11.2.1 CureSearch Company Details 11.2.2 CureSearch Business Overview 11.2.3 CureSearch Neuroblastoma Treatment Introduction 11.2.4 CureSearch Revenue in Neuroblastoma Treatment Business (2016-2021) 11.2.5 CureSearch Recent Development 11.3 Texas Children’s 11.3.1 Texas Children’s Company Details 11.3.2 Texas Children’s Business Overview 11.3.3 Texas Children’s Neuroblastoma Treatment Introduction 11.3.4 Texas Children’s Revenue in Neuroblastoma Treatment Business (2016-2021) 11.3.5 Texas Children’s Recent Development 11.4 NANT 11.4.1 NANT Company Details 11.4.2 NANT Business Overview 11.4.3 NANT Neuroblastoma Treatment Introduction 11.4.4 NANT Revenue in Neuroblastoma Treatment Business (2016-2021) 11.4.5 NANT Recent Development 11.5 Sino Biopharmaceutical 11.5.1 Sino Biopharmaceutical Company Details 11.5.2 Sino Biopharmaceutical Business Overview 11.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Introduction 11.5.4 Sino Biopharmaceutical Revenue in Neuroblastoma Treatment Business (2016-2021) 11.5.5 Sino Biopharmaceutical Recent Development 11.6 Jiangsu Hengrui Medicine Co.,Ltd. 11.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Details 11.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview 11.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Introduction 11.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Neuroblastoma Treatment Business (2016-2021) 11.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development 11.7 Fosun Pharmaceutical 11.7.1 Fosun Pharmaceutical Company Details 11.7.2 Fosun Pharmaceutical Business Overview 11.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Introduction 11.7.4 Fosun Pharmaceutical Revenue in Neuroblastoma Treatment Business (2016-2021) 11.7.5 Fosun Pharmaceutical Recent Development 11.8 Novartis 11.8.1 Novartis Company Details 11.8.2 Novartis Business Overview 11.8.3 Novartis Neuroblastoma Treatment Introduction 11.8.4 Novartis Revenue in Neuroblastoma Treatment Business (2016-2021) 11.8.5 Novartis Recent Development 11.9 Juno Therapeutics 11.9.1 Juno Therapeutics Company Details 11.9.2 Juno Therapeutics Business Overview 11.9.3 Juno Therapeutics Neuroblastoma Treatment Introduction 11.9.4 Juno Therapeutics Revenue in Neuroblastoma Treatment Business (2016-2021) 11.9.5 Juno Therapeutics Recent Development 11.10 Kite Pharma 11.10.1 Kite Pharma Company Details 11.10.2 Kite Pharma Business Overview 11.10.3 Kite Pharma Neuroblastoma Treatment Introduction 11.10.4 Kite Pharma Revenue in Neuroblastoma Treatment Business (2016-2021) 11.10.5 Kite Pharma Recent Development 11.11 Adaptimmune 11.11.1 Adaptimmune Company Details 11.11.2 Adaptimmune Business Overview 11.11.3 Adaptimmune Neuroblastoma Treatment Introduction 11.11.4 Adaptimmune Revenue in Neuroblastoma Treatment Business (2016-2021) 11.11.5 Adaptimmune Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Combination Chemotherapy Table 3. Key Players of Monoclonal Antibody Therapy Table 4. Key Players of Vaccine Therapy Table 5. Key Players of Chimeric Antigen Receptor T-Cell Immunotherapy Table 6. Key Players of Oncolytic Virus Therapy Table 7. Global Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Neuroblastoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Neuroblastoma Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Neuroblastoma Treatment Market Share by Regions (2016-2021) Table 11. Global Neuroblastoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Neuroblastoma Treatment Market Share by Regions (2022-2027) Table 13. Neuroblastoma Treatment Market Trends Table 14. Neuroblastoma Treatment Market Drivers Table 15. Neuroblastoma Treatment Market Challenges Table 16. Neuroblastoma Treatment Market Restraints Table 17. Global Neuroblastoma Treatment Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Neuroblastoma Treatment Market Share by Players (2016-2021) Table 19. Global Top Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Treatment as of 2020) Table 20. Ranking of Global Top Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Neuroblastoma Treatment Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Neuroblastoma Treatment Product Solution and Service Table 24. Date of Enter into Neuroblastoma Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million) Table 27. Global Neuroblastoma Treatment Revenue Market Share by Type (2016-2021) Table 28. Global Neuroblastoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Neuroblastoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Neuroblastoma Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Neuroblastoma Treatment Revenue Market Share by Application (2016-2021) Table 32. Global Neuroblastoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Neuroblastoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million) Table 35. North America Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million) Table 37. North America Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million) Table 64. Seattle Children’s Company Details Table 65. Seattle Children’s Business Overview Table 66. Seattle Children’s Neuroblastoma Treatment Product Table 67. Seattle Children’s Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 68. Seattle Children’s Recent Development Table 69. CureSearch Company Details Table 70. CureSearch Business Overview Table 71. CureSearch Neuroblastoma Treatment Product Table 72. CureSearch Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 73. CureSearch Recent Development Table 74. Texas Children’s Company Details Table 75. Texas Children’s Business Overview Table 76. Texas Children’s Neuroblastoma Treatment Product Table 77. Texas Children’s Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 78. Texas Children’s Recent Development Table 79. NANT Company Details Table 80. NANT Business Overview Table 81. NANT Neuroblastoma Treatment Product Table 82. NANT Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 83. NANT Recent Development Table 84. Sino Biopharmaceutical Company Details Table 85. Sino Biopharmaceutical Business Overview Table 86. Sino Biopharmaceutical Neuroblastoma Treatment Product Table 87. Sino Biopharmaceutical Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 88. Sino Biopharmaceutical Recent Development Table 89. Jiangsu Hengrui Medicine Co.,Ltd. Company Details Table 90. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview Table 91. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Table 92. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 93. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development Table 94. Fosun Pharmaceutical Company Details Table 95. Fosun Pharmaceutical Business Overview Table 96. Fosun Pharmaceutical Neuroblastoma Treatment Product Table 97. Fosun Pharmaceutical Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 98. Fosun Pharmaceutical Recent Development Table 99. Novartis Company Details Table 100. Novartis Business Overview Table 101. Novartis Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 102. Novartis Recent Development Table 103. Juno Therapeutics Company Details Table 104. Juno Therapeutics Business Overview Table 105. Juno Therapeutics Neuroblastoma Treatment Product Table 106. Juno Therapeutics Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 107. Juno Therapeutics Recent Development Table 108. Kite Pharma Company Details Table 109. Kite Pharma Business Overview Table 110. Kite Pharma Neuroblastoma Treatment Product Table 111. Kite Pharma Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 112. Kite Pharma Recent Development Table 113. Adaptimmune Company Details Table 114. Adaptimmune Business Overview Table 115. Adaptimmune Neuroblastoma Treatment Product Table 116. Adaptimmune Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million) Table 117. Adaptimmune Recent Development Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Global Neuroblastoma Treatment Market Share by Type: 2020 VS 2027 Figure 2. Combination Chemotherapy Features Figure 3. Monoclonal Antibody Therapy Features Figure 4. Vaccine Therapy Features Figure 5. Chimeric Antigen Receptor T-Cell Immunotherapy Features Figure 6. Oncolytic Virus Therapy Features Figure 7. Global Neuroblastoma Treatment Market Share by Application: 2020 VS 2027 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Others Case Studies Figure 11. Neuroblastoma Treatment Report Years Considered Figure 12. Global Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Neuroblastoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Neuroblastoma Treatment Market Share by Regions: 2020 VS 2027 Figure 15. Global Neuroblastoma Treatment Market Share by Regions (2022-2027) Figure 16. Global Neuroblastoma Treatment Market Share by Players in 2020 Figure 17. Global Top Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Treatment as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Neuroblastoma Treatment Revenue in 2020 Figure 19. Global Neuroblastoma Treatment Revenue Market Share by Type (2016-2021) Figure 20. Global Neuroblastoma Treatment Revenue Market Share by Type (2022-2027) Figure 21. North America Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Neuroblastoma Treatment Market Share by Type (2016-2027) Figure 23. North America Neuroblastoma Treatment Market Share by Application (2016-2027) Figure 24. North America Neuroblastoma Treatment Market Share by Country (2016-2027) Figure 25. United States Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Neuroblastoma Treatment Market Share by Type (2016-2027) Figure 29. Europe Neuroblastoma Treatment Market Share by Application (2016-2027) Figure 30. Europe Neuroblastoma Treatment Market Share by Country (2016-2027) Figure 31. Germany Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Neuroblastoma Treatment Market Share by Type (2016-2027) Figure 39. Asia-Pacific Neuroblastoma Treatment Market Share by Application (2016-2027) Figure 40. Asia-Pacific Neuroblastoma Treatment Market Share by Region (2016-2027) Figure 41. China Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Neuroblastoma Treatment Market Share by Type (2016-2027) Figure 49. Latin America Neuroblastoma Treatment Market Share by Application (2016-2027) Figure 50. Latin America Neuroblastoma Treatment Market Share by Country (2016-2027) Figure 51. Mexico Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Neuroblastoma Treatment Market Share by Type (2016-2027) Figure 55. Middle East & Africa Neuroblastoma Treatment Market Share by Application (2016-2027) Figure 56. Middle East & Africa Neuroblastoma Treatment Market Share by Country (2016-2027) Figure 57. Turkey Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Seattle Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 61. CureSearch Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 62. Texas Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 63. NANT Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 64. Sino Biopharmaceutical Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 65. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 66. Fosun Pharmaceutical Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 67. Novartis Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 68. Juno Therapeutics Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 69. Kite Pharma Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 70. Adaptimmune Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Seattle Children’s CureSearch Texas Children’s NANT Sino Biopharmaceutical Jiangsu Hengrui Medicine Co.,Ltd. Fosun Pharmaceutical Novartis Juno Therapeutics Kite Pharma Adaptimmune